Batcheler L M, Bonham D G, Collins R, Liddell H S
Aust N Z J Obstet Gynaecol. 1986 Aug;26(3):239-41. doi: 10.1111/j.1479-828x.1986.tb01576.x.
Thirty-five women with primary herpes genitalis and 34 women with recurrent herpes genitalis were treated with either placebo, or beta Interferon cream (20,000 iu/g). In comparison with the placebo group, the treatment group showed no benefit in either symptom relief, speed of healing of lesions or length of viral shedding time from lesions.
35名原发性生殖器疱疹女性患者和34名复发性生殖器疱疹女性患者分别接受了安慰剂或β干扰素乳膏(20,000国际单位/克)治疗。与安慰剂组相比,治疗组在症状缓解、病损愈合速度或病损病毒排出时间长度方面均未显示出益处。